1. Home
  2. NXTS vs PRFX Comparison

NXTS vs PRFX Comparison

Compare NXTS & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$0.69

Market Cap

2.5M

Sector

Industrials

ML Signal

N/A

Logo PainReform Ltd.

PRFX

PainReform Ltd.

N/A

Current Price

$2.18

Market Cap

2.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXTS
PRFX
Founded
2009
2007
Country
Israel
Israel
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NXTS
PRFX
Price
$0.69
$2.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
53.2K
27.6K
Earning Date
03-27-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$0.58
52 Week High
$1.10
$3.71

Technical Indicators

Market Signals
Indicator
NXTS
PRFX
Relative Strength Index (RSI) 25.50 39.32
Support Level $0.65 $1.28
Resistance Level $1.10 $3.65
Average True Range (ATR) 0.10 0.23
MACD -0.02 -0.12
Stochastic Oscillator 13.72 8.99

Price Performance

Historical Comparison
NXTS
PRFX

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: